Base10 Genetics - About the company
Base10 Genetics is a funded company based in Chicago (United States), founded in 2017. It operates as a Provider of software for managing healthcare costs for employees. The company has 51 active competitors, including 17 funded and 5 that have exited. Its top competitors include companies like NantHealth, SamaCare and OncoHealth.
Company Details
Base 10 provides software for managing healthcare costs for employees. It provides personalized genetic reports and disease prevention and management. It provides cost savings options through employee medication management and wellness. It also uses big-data technology to manage health and financial outcome for employees.
- Website
- base10genetics.com
- Email ID
- *****@base10genetics.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2017
Location
Chicago, United States
Stage
Funding Raised
Investors
Ranked
27th among 51 active competitors
Employee Count
5 as on Mar 31, 2026
Similar Companies
Sign up to download Base10 Genetics' company profile
Base10 Genetics's funding and investors
Base10 Genetics is a funded company. Base10 Genetics has 1 institutional investor.
View details of Base10 Genetics's funding rounds and investors
Base10 Genetics' founders and board of directors
Founder? Claim ProfileBase10 Genetics' employee count trend
Base10 Genetics has 5 employees as of Mar 26. Here is Base10 Genetics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Base10 Genetics's Competitors and alternates
Top competitors of Base10 Genetics include NantHealth, SamaCare and OncoHealth. Here is the list of Top 10 competitors of Base10 Genetics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | NantHealth 2007, El Segundo (United States), Public | Provider of bioinformatics platform to find treatment for cancer and other diseases | $608M | 65/100 | |
2nd | SamaCare 2010, San Francisco (United States), Series B | Provider of platform to manage prior authorisation solutions | $34.8M | 64/100 | |
3rd | OncoHealth 2009, Atlanta (United States), Acquired | Online platform providing health solutions for providers and patients involved in cancer care. | $56.5M | 62/100 | |
4th | Humata 2023, Winter Park (United States), Series B | Platform offering prior authorization processes through AI and automation | $25M | 58/100 | |
5th | Cohere Health 2019, Boston (United States), Series C | Provider of prior authorization solutions to improve patient care | $200M | 58/100 | |
6th | Glidian 2016, Palo Alto (United States), Acquired | Streamlining prior authorizations for healthcare providers through technology and expert support | - | 58/100 | |
7th | Arrive Health 2013, Denver (United States), Series B | Provider of information services to patients | $62.5M | 57/100 | |
8th | Basys.ai 2022, Cambridge (United States), Seed | Provider of SaaS-based platform for clinical decision-making for doctors at hospitals | $2.4M | 56/100 | |
9th | Silna Health 2023, New York City (United States), Series A | Provider of healthcare company specializing in automating benefits and prior authorization processes for providers | $27M | 47/100 | |
10th | Develop Health 2022, Menlo Park (United States), Series A | Provider of AI-powered prior authorization solutions for healthcare | $31.9M | 44/100 | |
27th | Base10 Genetics 2017, Chicago (United States), Funding Raised | Provider of software for managing healthcare costs for employees | - | 23/100 |
Looking for more details on Base10 Genetics's competitors? Click here to see the top ones
Base10 Genetics's Investments and acquisitions
Base10 Genetics has made no investments or acquisitions yet.
Reports related to Base10 Genetics
Here is the latest report on Base10 Genetics's sector:
News related to Base10 Genetics
•
Base10 Genetics Recalls Specimen Collection Kit for Viral TestingGenomeWeb•Feb 19, 2022•Base10 Genetics
•
•
BASE10 and DNA Link COVID-19 Antibody Test Yields Promising Resultssvdaily.com•Sep 02, 2020•Base10 Genetics
Are you a Founder ?
FAQs about Base10 Genetics
Explore our recently published companies
- Pennyjonesmortgages - United Kingdom based, Unfunded company
- Pembertonassociates - 1999 founded, Unfunded company
- Hydrogenvalves - United Kingdom based, Unfunded company
- Electriclock - United Kingdom based, Unfunded company
- Electrotechdrives - United Kingdom based, 2003 founded, Unfunded company
- Pentangle Engineering - United Kingdom based, Unfunded company